Article / Sep 10, 2024
Sustainable API development guided by historical and AI evaluation
Specialty Chemicals Magazine, September/October 2024
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Commitment to partnership and joint innovation for cell and gene therapies
A partnership to accelerate the development of the Dispersome® technology platform and further expand its applicability and reach for increasing the solubility and bioavailability of small drug molecules.
Excipient and delivery device selection play crucial roles in the formulation of inhaled drugs.